Your browser doesn't support javascript.
loading
Research progress of circRNA in malignant tumour metabolic reprogramming.
Geng, Yikun; Wang, Min; Wu, Zhouying; Jia, Jianchao; Yang, Tingyu; Yu, Lan.
Affiliation
  • Geng Y; Graduate school, Inner Mongolia Medical University, Hohhot, China.
  • Wang M; Clinical Medical Research Center, Inner Mongolian People's Hospital, Hohhot, China.
  • Wu Z; Clinical Medical Research Center, Inner Mongolian People's Hospital, Hohhot, China.
  • Jia J; Inner Mongolia Key Laboratory of Gene Regulation of The Metabolic Disease, Inner Mongolian People's Hospital, Hohhot, China.
  • Yang T; Inner Mongolia Academy of Medical Sciences, Inner Mongolian People's Hospital, Hohhot, China.
  • Yu L; Clinical Medical Research Center, Inner Mongolian People's Hospital, Hohhot, China.
RNA Biol ; 20(1): 641-651, 2023 01.
Article in En | MEDLINE | ID: mdl-37599427
ABSTRACT
Cancer is a multi-factor systemic malignant disease, which has seriously threatened human health and created a heavy burden on the world economy. Metabolic reprogramming, one of the important signs of malignant tumours, provides necessary nutrition for tumorigenesis and cancer development; thus, it has recently become a research hot spot, even though the metabolic mechanism is quite intricate. Circular RNA (circRNA) affects cancer cell metabolism through various molecular mechanisms, playing an important role in promoting or suppressing cancer. Because of the structure characteristics, circRNA is quite stable, and can be utilized as biomarkers. In this review, we analysed and summarized the characteristics and biological functions of circRNA and comprehensively reviewed and discussed the important role of circRNA in cancer metabolic reprogramming. This review will provide new ideas for developing new anti-cancer therapeutic targets, mining cancer diagnostic and prognostic markers, and will provide guidance for other researchers to design circRNA-related experiments and develop anti-tumour drugs.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Circular / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: RNA Biol Journal subject: BIOLOGIA MOLECULAR Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Circular / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: RNA Biol Journal subject: BIOLOGIA MOLECULAR Year: 2023 Type: Article Affiliation country: China